These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 582406)

  • 21. Effects of morphine on urine flow in rats. Involvement of vasopressin.
    Michel C; Montastruc JL; Valdiguié P; Montastruc P
    J Pharmacol; 1986; 17(3):316-22. PubMed ID: 3795975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonidine-induced diuresis in the rat: evidence for a renal site of action.
    Miller M
    J Pharmacol Exp Ther; 1980 Sep; 214(3):608-13. PubMed ID: 7400963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.
    Ohnishi A; Orita Y; Okahara R; Fujihara H; Inoue T; Yamamura Y; Yabuuchi Y; Tanaka T
    J Clin Invest; 1993 Dec; 92(6):2653-9. PubMed ID: 8254021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose selective dissociation of water and solute excretion after renal alpha-2 adrenoceptor stimulation.
    Blandford DE; Smyth DD
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1181-6. PubMed ID: 2849664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of somatostatin on vasopressin-induced antidiuresis and renal cyclic AMP of rats.
    Winkler SN; Torikai S; Levine BS; Kurokawa K
    Miner Electrolyte Metab; 1982 Jan; 7(1):8-14. PubMed ID: 6133212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nalfurafine, a G-Protein-Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics.
    Meariman JK; Sutphen JC; Gao J; Kapusta DR
    Hypertension; 2022 Feb; 79(2):379-390. PubMed ID: 34852633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender effect on diuretic response to hydrochlorothiazide and furosemide.
    Franson KL; Kuk JM; Lam NP; Lau AH
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):101-5. PubMed ID: 8705087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal effects of intracerebroventricularly injected tachykinins in the conscious saline-loaded rat: receptor characterization.
    Yuan YD; Couture R
    Br J Pharmacol; 1997 Mar; 120(5):785-96. PubMed ID: 9138683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and chronic diuretic-induced alterations in urinary sodium and calcium excretion in the conscious rat.
    Hanson RC; White JB; Gomoll AW
    Miner Electrolyte Metab; 1982 Dec; 8(6):314-24. PubMed ID: 7167137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of renal dopamine synthesis in the diuretic effect of furosemide in normohydrated rats.
    Nowicki S; Levin G; Enero MA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1377-80. PubMed ID: 8450472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of effect of prostaglandin E 1 on renal water excretion.
    Berl T; Schrier RW
    J Clin Invest; 1973 Feb; 52(2):463-71. PubMed ID: 4683884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diuretic activity of the aqueous extracts of Carum carvi and Tanacetum vulgare in normal rats.
    Lahlou S; Tahraoui A; Israili Z; Lyoussi B
    J Ethnopharmacol; 2007 Apr; 110(3):458-63. PubMed ID: 17113735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal and antihypertensive effects of a novel eukalemic diuretic, ICI 207,828.
    Kau ST; Howe BB; Johnston PA; Li JH; Halterman TJ; Zuzack JS; Leszczynska K; Yochim CL; Schwartz JA; Giles RE
    J Pharmacol Exp Ther; 1992 Feb; 260(2):450-7. PubMed ID: 1738094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The water diuretic effect of the alpha-2 adrenoceptor agonist, AGN 190851, is species-dependent.
    Brooks DP; Edwards RM; Depalma PD; Fredrickson TA; Hieble JP; Gellai M
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1277-82. PubMed ID: 1684820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
    Bishara B; Shiekh H; Karram T; Rubinstein I; Azzam ZS; Abu-Saleh N; Nitecki S; Winaver J; Hoffman A; Abassi ZA
    J Pharmacol Exp Ther; 2008 Aug; 326(2):414-22. PubMed ID: 18467593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CVT-124, a novel adenosine A1 receptor antagonist with unique diuretic activity.
    Gellai M; Schreiner GF; Ruffolo RR; Fletcher T; DeWolf R; Brooks DP
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1191-6. PubMed ID: 9732378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine.
    Slizgi GR; Ludens JH
    J Pharmacol Exp Ther; 1982 Mar; 220(3):585-91. PubMed ID: 6121047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Furosemide renal excretion rate and the effects of the diuretic on different tubular sites are modified by endogenous dopamine in normohydrated rats.
    Nowicki S; Opezzo JA; Levin G; Gonzalez D; Elias MM
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1348-54. PubMed ID: 7562507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of diuretics after pretreatment with reserpine and 6-OH-dopamine (author's transl)].
    Hörl WH; Hennemann HM; Heidland A
    Arzneimittelforschung; 1976 Apr; 26(4):539-43. PubMed ID: 989009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin-vasopressin interactions on the renal handling of calcium and magnesium.
    Roman RJ; Skelton M; Lechene C
    J Pharmacol Exp Ther; 1984 Aug; 230(2):295-301. PubMed ID: 6589391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.